Core Insights - Globant and LALIGA have signed a Memorandum of Understanding (MoU) to transform LALIGA's operations through the adoption of artificial intelligence (AI) [1][4] - The partnership will utilize Globant's AI Pods subscription model, which consists of teams of AI agents supervised by experts to enhance operational efficiency [2][4] - The collaboration aims to create AI agents in key areas such as talent development, operations, and technology to improve sports performance analysis and workflow automation [3][4] Company Overview - Globant is a digitally native company focused on reinventing businesses through innovative technology solutions, with a strong emphasis on AI and digital transformation [1][8] - LALIGA is the largest football ecosystem globally, comprising 20 clubs in LALIGA EA SPORTS and 22 in LALIGA HYPERMOTION, with a significant social media following of over 258 million [6][7] Strategic Goals - LALIGA aims to incorporate AI as a strategic pillar for operational excellence and to modernize its competition, enhancing fan engagement [4] - The partnership is expected to set a precedent in the sports industry by being the first global sports organization to adopt agentic AI models [4][5] Technological Impact - The AI Pods model has been successfully implemented in various industries, including aviation and banking, indicating its potential for scalability and effectiveness in sports [2][3] - Sportian, the joint venture between Globant and LALIGA, will leverage AI to create a comprehensive suite of technological solutions for sports organizations [3][5]

Core Viewpoint - Azitra, Inc. has refuted claims regarding a false report of a $44 million registered direct offering, urging stakeholders to rely on official communications from the company [1][2]. Company Overview - Azitra, Inc. is a clinical stage biopharmaceutical company focused on precision dermatology, with its lead program ATR-12 targeting Netherton syndrome, a rare skin disease with no approved treatments [3]. - The ATR-12 program is currently in a Phase 1b clinical trial for adult patients with Netherton syndrome [3]. - Azitra's ATR-04 program addresses EGFR inhibitor-associated rash and has received Fast Track designation from the FDA, impacting approximately 150,000 individuals in the U.S. [3]. - The company is also advancing ATR-01, a preclinical program for ichthyosis vulgaris, with plans for an IND submission in 2026 [3]. - Azitra's proprietary platform includes a microbial library of around 1,500 bacterial strains, enhanced by AI and machine learning technologies for drug discovery [3].

RETRANSMISSION: HIVE Digital Technologies to Release Fiscal Q2 2026 Financial Results and Hold Earnings Call on November 17November 07, 2025 6:00 AM EST | Source: HIVE Digital Technologies Ltd.San Antonio, Texas--(Newsfile Corp. - November 7, 2025) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE"), a diversified multinational digital infrastructure company, today announced it will release its financial results for the six months ended September 3 ...

CUPERTINO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ambow Education Holding Ltd. (“Ambow” or the “Company”) (NYSE American: AMBO), a global innovator of AI-powered phygital (physical + digital) solutions for education, conferencing and events, today announced that it has entered into a strategic cooperation agreement with The Forensic CPA Society (“FCPAS”). Under the agreement, FCPAS will adopt Ambow’s HybriU™ platform to deliver its forensic accounting training modules and certification programs worldwide ...

CALGARY, AB / ACCESS Newswire / November 7, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) (" Primary " or the " Company ") is pleased to announce the identification of two significant rare earth element (REE) anomaly clusters following completion of comprehensive geophysical and soil sampling surveys at its Wicheeda North REE Project (" Wicheeda North " or the " Project ") in British Columbia. Key Highlights Completed 401 line-kilometre airborne VTEM and magnetic survey covering 25 square ...

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Today, November 7, 2025, Emera Inc. ("Emera†) (TSX/NYSE: EMA) reported financial results for the third quarter and year-to-date 2025 and released details about its 2026-2030 capital plan. Highlights Delivered 9% improvement in adjusted earnings per share1 ("EPS†) for the third quarter of 2025, with $0.88 of adjusted EPS and $0.76 of reported EPS. Introduced 5-year $20 billion capital plan and extended 7-8% rate base growth guidance through 2030 with approx. ...

MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2025. Yogi Jashnani, Chief Executive Officer, stated: “During the quarter, we made strong progress on our key initiatives that focused on new growth opportunities, margin improvement, and debt reduction. While third quarter revenue was lower than anticipated, ...

Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recurring revenue, which includes consumables and annual service contracts, increased 32% compared to the third quarter of 2024 driven by record consumable revenue. Reports third quarter gross margin of 9%, representing a 70-basis point improvement compared to the third quarter of 2024.Announces record multi-system order from an existing Top 20 global biopharma customer ...

Core Insights - Docebo Inc. reported strong financial results for Q3 2025, exceeding expectations due to its AI-First platform strategy and growing partnerships in federal and SLED markets [2][5][8] Financial Highlights - Subscription revenue reached $58.0 million, a 10% increase year-over-year, accounting for 94% of total revenue [5][12] - Total revenue was $61.6 million, reflecting an 11% increase from the previous year [5][12] - Gross profit was $49.5 million, representing 80.3% of total revenue, compared to 81.1% in the prior year [5][12] - Net income increased to $6.1 million, or $0.21 per share, up from $5.0 million, or $0.16 per share, in the same period last year [5][12] - Adjusted Net Income was $9.9 million, or Adjusted Earnings per share of $0.34, compared to $8.3 million, or $0.27 per share, in the prior year [5][12] - Annual Recurring Revenue (ARR) was $235.6 million, a 10.1% increase year-over-year [5][12] - Adjusted EBITDA was $12.4 million, representing 20.1% of total revenue, compared to 15.7% in the prior year [5][12] Customer Updates - Notable new customers include a global provider in industrial and environmental services with over 200,000 employees, and the Latvian School of Public Administration, which serves over 60,000 employees [4][10] - Docebo also secured contracts with Amazon Health and the U.S. Department of Energy, highlighting its growing presence in government and education sectors [10] Financial Outlook - For Q4 2025, management expects subscription revenue growth to align with total revenue growth [8][11] - Revised guidance for the fiscal year ending December 31, 2025, anticipates total revenue growth of approximately 11.40% and subscription revenue growth of 11.75% [11]

For wealthy Americans, business is taking off — literally. That’s thanks to a revived tax break from the first Trump administration, called bonus depreciation. Must Read Bonus depreciation lets businesses write off 100% of big-ticket business purchases like new tech, equipment, or upgrades in the year they are purchased. By front-loading those tax breaks, the policy gives companies a reason to spend now — nominally fueling investment, productivity, higher pay, and new jobs down the line, according to th ...